The biotechnology company focused on clinical-stage drug discovery, development, and manufacturing, Sutro Biopharma Inc. (NASDAQ: STRO) seems to be gearing up for a surge as per its latest charts.
#1 Symmetrical Triangle Pattern Breakout: The daily chart shows that the stock has currently broken out of a symmetrical triangle pattern which is a possible bullish sign. A symmetrical triangle is a continuation pattern and is characterized by two converging trendlines connecting a series of sequential peaks and troughs. This is marked on the daily chart as pink color lines.
#2 Trading above MAs: The price is currently above its short-term moving average of 50-day SMA as well as its longer-term moving average of 200-day SMA. This implies a possible bullish bias for the stock.
#4 Bullish ADX and DI: The ADX line has started to move up from below –DI and +DI lines. The +DI line and the ADX line is also currently above the –DI line. This indicates possible bullishness.
#5 Bullish Aroon: The value of Aroon Up (orange line) is above 70 while Aroon Down (blue line) is below 30 in the daily chart. This indicates possible bullishness.
#6 Consolidation Area: The weekly chart shows that the stock has been consolidating within a price range for the past several weeks. This area is marked as a purple color rectangle. Once the stock breaks out from this range, it could move higher.
#7 Bullish Stoch: The %K line is currently above the %D line of the stochastic in the weekly chart, indicating possible bullishness.
Recommended Trade (based on the charts)
Buy Levels: If you want to get in on this trade, the ideal buy level for STRO is above the price of $12.00
However, you can purchase half the intended quantity of shares of STRO if it trades above yesterday’s high, at around $11.30
TP: Our target prices are $16 and $20 in the next 3-6 months.
SL: To limit risk, place a stop loss at $9.60. Note that this stop loss is on a closing basis.
Our target potential upside is nearly 33% to 77% in the next 3-6 months.
- Entry near $11.30: For a risk of $1.70, the target rewards are $4.70 and $8.70. This is a nearly 1:3 and 1:5 risk-reward trade.
- Entry near $12.00: For a risk of $2.40, the target rewards are $4.00 and $8.00. This is a nearly 1:2 and 1:3 risk-reward trade.
In other words, this trade offers nearly 2x to 5x more potential upside than downside.
Risks to Consider
The stock may reverse its overall trend if it breaks down with high volume from the symmetrical triangle pattern. The sell-off of the stock could also be triggered in case of any negative news, overall weakness in the market, or any regulatory changes in its sector.
Bill Bonner went to law school with Fed Chair Jerome Powell... Co-authored 3 New York Times Best-sellers... And is one of America's most successful entrepreneurs. Bonner's made 3 big macro-economic predictions in his 40-year career, all of which came true. Now he's issuing his 4th and Final Warning. 2023 could be a difficult year for you and your money. See Bonner's warning and 4 recommended steps here...